• Clearmind Medicine entered an agreement on May 18, 2026 to issue and sell convertible promissory notes with an aggregate principal amount of USD 600,000 to existing investors.
• Cash proceeds are expected to total USD 540,000, reflecting a 90% purchase price to principal.
• The transaction is expected to close on or about May 19, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-058428), on May 18, 2026, and is solely responsible for the information contained therein.